Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUPRIYA LIFESCIENCE vs NATCO PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUPRIYA LIFESCIENCE NATCO PHARMA SUPRIYA LIFESCIENCE /
NATCO PHARMA
 
P/E (TTM) x 36.0 12.7 284.1% View Chart
P/BV x 7.0 4.2 165.2% View Chart
Dividend Yield % 0.1 0.7 16.4%  

Financials

 SUPRIYA LIFESCIENCE    NATCO PHARMA
EQUITY SHARE DATA
    SUPRIYA LIFESCIENCE
Mar-24
NATCO PHARMA
Mar-24
SUPRIYA LIFESCIENCE /
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs3941,108 35.5%   
Low Rs191550 34.6%   
Sales per share (Unadj.) Rs61.4223.3 27.5%  
Earnings per share (Unadj.) Rs14.877.5 19.1%  
Cash flow per share (Unadj.) Rs16.887.9 19.1%  
Dividends per share (Unadj.) Rs0.809.50 8.4%  
Avg Dividend yield %0.31.1 23.9%  
Book value per share (Unadj.) Rs101.3326.8 31.0%  
Shares outstanding (eoy) m80.48179.11 44.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.83.7 128.2%   
Avg P/E ratio x19.710.7 184.6%  
P/CF ratio (eoy) x17.49.4 184.9%  
Price / Book Value ratio x2.92.5 113.7%  
Dividend payout %5.412.3 44.1%   
Avg Mkt Cap Rs m23,517148,509 15.8%   
No. of employees `000NANA-   
Total wages/salary Rs m6765,250 12.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m4,93839,988 12.3%  
Other income Rs m1101,281 8.6%   
Total revenues Rs m5,04741,269 12.2%   
Gross profit Rs m1,75717,514 10.0%  
Depreciation Rs m1581,868 8.5%   
Interest Rs m51192 26.8%   
Profit before tax Rs m1,65716,735 9.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m4662,852 16.3%   
Profit after tax Rs m1,19113,883 8.6%  
Gross profit margin %35.643.8 81.2%  
Effective tax rate %28.117.0 164.9%   
Net profit margin %24.134.7 69.5%  
BALANCE SHEET DATA
Current assets Rs m4,00540,235 10.0%   
Current liabilities Rs m7969,728 8.2%   
Net working cap to sales %65.076.3 85.2%  
Current ratio x5.04.1 121.7%  
Inventory Days Days4862 76.9%  
Debtors Days Days83109 76.1%  
Net fixed assets Rs m5,23428,634 18.3%   
Share capital Rs m161358 45.0%   
"Free" reserves Rs m7,99358,173 13.7%   
Net worth Rs m8,15458,531 13.9%   
Long term debt Rs m00-   
Total assets Rs m9,23968,869 13.4%  
Interest coverage x33.288.2 37.6%   
Debt to equity ratio x00-  
Sales to assets ratio x0.50.6 92.0%   
Return on assets %13.420.4 65.8%  
Return on equity %14.623.7 61.6%  
Return on capital %21.028.9 72.5%  
Exports to sales %91.10-   
Imports to sales %16.19.5 169.1%   
Exports (fob) Rs m4,498NA-   
Imports (cif) Rs m7933,798 20.9%   
Fx inflow Rs m4,49827,347 16.4%   
Fx outflow Rs m7933,798 20.9%   
Net fx Rs m3,70523,549 15.7%   
CASH FLOW
From Operations Rs m1,13312,116 9.4%  
From Investments Rs m-1,736-10,327 16.8%  
From Financial Activity Rs m-224-2,469 9.1%  
Net Cashflow Rs m-826-615 134.4%  

Share Holding

Indian Promoters % 68.3 49.6 137.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 11.5 24.3 47.3%  
FIIs % 6.0 17.5 34.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 50.4 62.9%  
Shareholders   85,328 302,944 28.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUPRIYA LIFESCIENCE With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    MANKIND PHARMA    


More on SUPRIYA LIFESCIENCE vs Natco Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

SUPRIYA LIFESCIENCE vs Natco Pharma Share Price Performance

Period SUPRIYA LIFESCIENCE Natco Pharma S&P BSE HEALTHCARE
1-Day 2.18% 0.61% 0.11%
1-Month 30.51% 0.26% -3.22%
1-Year 186.76% 76.43% 42.65%
3-Year CAGR 21.73% 19.45% 19.86%
5-Year CAGR 12.52% 19.87% 25.90%

* Compound Annual Growth Rate

Here are more details on the SUPRIYA LIFESCIENCE share price and the Natco Pharma share price.

Moving on to shareholding structures...

The promoters of SUPRIYA LIFESCIENCE hold a 68.3% stake in the company. In case of Natco Pharma the stake stands at 49.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of SUPRIYA LIFESCIENCE and the shareholding pattern of Natco Pharma.

Finally, a word on dividends...

In the most recent financial year, SUPRIYA LIFESCIENCE paid a dividend of Rs 0.8 per share. This amounted to a Dividend Payout ratio of 5.4%.

Natco Pharma paid Rs 9.5, and its dividend payout ratio stood at 12.3%.

You may visit here to review the dividend history of SUPRIYA LIFESCIENCE , and the dividend history of Natco Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Falls 423 Points | Nifty Ends Near 23,350 | Adani Enterprises Cracks 23% Sensex Today Falls 423 Points | Nifty Ends Near 23,350 | Adani Enterprises Cracks 23%(Closing)

On Thursday, Indian share markets traded lower throughout the trading session and ended on a weak note.